KY-1043

N/A

Report date: 2024/01/05 14:01:38

Base Information

Drug NameKY-1043

Drug Alias NameKY-1043KY1043

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanBiologics > Protein drugs > Recombinant protein > Fusion protein

Mechanisms of ActionProgrammed death-ligand 1 blockersAnti-Programmed death-ligand 1

TargetsProgrammed death-ligand 1Interleukin-2 receptor alpha chain

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited Kingdom

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesKymab Ltd

China Registration ClassN/A

Develop Information

Active CompaniesKymab Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A